Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 160

Propzy prepares $25m series B round

GS Shop-backed real estate marketplace Propzy is seeking $25m to fund the launch of new services and enter new geographical markets.

Aug 13, 2019

Clobotics clubs investors together to raise $22m

Wangsu-backed computer vision technology developer Clobotics has received pre-series B financing to extend its overall funding to at least $48m.

Aug 13, 2019

Tastytrade coughs up $20m for Dough

Investment brokerage app developer has Dough received $20m from financial intelligence group and parent company Tastytrade ahead of a planned launch next month.

Aug 12, 2019

WSC Sports wins $23m

Ofer Global, NTT Docomo, Harris Blitzer Sports & Entertainment, Intel and Go4It all signed up to a round that brought sports content management platform WSC's total funding to $39m.

Aug 12, 2019

Glycomine glides to $33m series B round

The orphan disease drug developer's latest round was led by Novo while Asahi Kasei and Chiesi Ventures also participated, taking its overall funding to $46m.

Aug 9, 2019

Cloudleaf collects $26m series B funding

Exiting investor Mahindra Partners contributed to an Intel Capital-led round that increased the industrial internet-of-things technology developer's total funding to $39m.

Aug 9, 2019

Glycomine digs up $33m series B

Mission Bay Capital has backed a series B round for orphan diseases drug developer Glycomine, which also attracted Novo, Asahi Kasei Pharma and Chiesi.

Aug 9, 2019

Experian credits CompareAsiaGroup in $20m round

Experian led a sereis B1 round for the Alibaba and SBI Group-backed Southeast Asia-focused financial comparison platform to take its total funding to about $115m.

Aug 8, 2019

Sagimet settles series E at $25m

3-V Biosciences has changed its name to Sagimet Biosciences after closing a series E round backed by strategic partner Ascletis at $25m.

Aug 7, 2019

IVX Health invites McKesson to latest round

Existing investor McKesson Ventures co-led the $22.5m round, which will enable IVX Health to open additional infusion and injection therapies centres.

Aug 7, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here